• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRD4-SRPK2-SRSF2 信号调节 ACSL3 前体 mRNA 的剪接效率,并影响骨肉瘤细胞中 erastin 诱导的铁死亡。

The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells.

机构信息

Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Department of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

出版信息

Cell Death Dis. 2023 Nov 23;14(11):760. doi: 10.1038/s41419-023-06273-2.

DOI:10.1038/s41419-023-06273-2
PMID:37993451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10665344/
Abstract

Lipid metabolism is the key to ferroptosis susceptibility. However, little is known about the underlying mechanisms in osteosarcoma cells. Functional restriction of bromodomain-containing protein 4 (BRD4) reduced the susceptibility to erastin-induced ferroptosis of osteosarcoma cells both in vitro and in vivo. Mechanically, BRD4 controls the splicing efficiency of the RNA precursor (pre-mACSL3) of ACSL3 (ACSL3) by recruiting serinerich/threonine protein kinase 2 (SRPK2) to assemble the splicing catalytic platform. Moreover, the AMP-binding domain of ACSL3 significantly influences arachidonic acid synthesis and thus determines the susceptibility to erastin-induced ferroptosis. Overall, we found a BRD4-mediated pre-mACSL3 splicing influences erastin-induced ferroptosis by affecting arachidonic acid synthesis in osteosarcoma cells. Data in this study fills some of the gap in understanding the post-transcriptional regulatory mechanisms of ACSL3 and provides new insights into the mechanisms of lipid metabolism regulation and its effect on susceptibility to ferroptosis in osteosarcoma cells.

摘要

脂质代谢是铁死亡易感性的关键。然而,骨肉瘤细胞中潜在的机制知之甚少。溴结构域蛋白 4(BRD4)的功能限制减少了骨肉瘤细胞对 erastin 诱导的铁死亡的易感性,无论是在体外还是体内。在机制上,BRD4 通过招募丝氨酸/苏氨酸蛋白激酶 2(SRPK2)组装剪接催化平台,控制 ACSL3(ACSL3)的 RNA 前体(pre-mACSL3)的剪接效率。此外,ACSL3 的 AMP 结合域显著影响花生四烯酸的合成,从而决定了对 erastin 诱导的铁死亡的敏感性。总的来说,我们发现 BRD4 介导的 pre-mACSL3 剪接通过影响骨肉瘤细胞中花生四烯酸的合成来影响 erastin 诱导的铁死亡。本研究中的数据填补了理解 ACSL3 的转录后调控机制的一些空白,并为脂质代谢调节及其对骨肉瘤细胞铁死亡易感性的影响机制提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/b7f8cd4ffa18/41419_2023_6273_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/a6059b5efe51/41419_2023_6273_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/eb336485cac0/41419_2023_6273_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/b2466f1c047b/41419_2023_6273_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/39745f78da87/41419_2023_6273_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/359d26b44872/41419_2023_6273_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/9504e307ed2b/41419_2023_6273_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/af17f57f5b5d/41419_2023_6273_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/b7f8cd4ffa18/41419_2023_6273_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/a6059b5efe51/41419_2023_6273_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/eb336485cac0/41419_2023_6273_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/b2466f1c047b/41419_2023_6273_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/39745f78da87/41419_2023_6273_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/359d26b44872/41419_2023_6273_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/9504e307ed2b/41419_2023_6273_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/af17f57f5b5d/41419_2023_6273_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b086/10665344/b7f8cd4ffa18/41419_2023_6273_Fig8_HTML.jpg

相似文献

1
The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells.BRD4-SRPK2-SRSF2 信号调节 ACSL3 前体 mRNA 的剪接效率,并影响骨肉瘤细胞中 erastin 诱导的铁死亡。
Cell Death Dis. 2023 Nov 23;14(11):760. doi: 10.1038/s41419-023-06273-2.
2
Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis.溴结构域蛋白 4(BRD4)作为脂肪酸代谢基因和铁死亡的表观遗传调节剂。
Cell Death Dis. 2022 Oct 29;13(10):912. doi: 10.1038/s41419-022-05344-0.
3
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.非小细胞肺癌中前体 mRNA 剪接调节剂 SRSF1、SRSF2、SRPK1 和 SRPK2 的异常表达。
PLoS One. 2012;7(10):e46539. doi: 10.1371/journal.pone.0046539. Epub 2012 Oct 10.
4
Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3/SLC7A11 pathway.丁酸盐通过调节 ATF3/SLC7A11 通路增强依维莫司诱导的骨肉瘤细胞铁死亡。
Eur J Pharmacol. 2023 Oct 15;957:176009. doi: 10.1016/j.ejphar.2023.176009. Epub 2023 Aug 22.
5
Paraquat modulates alternative pre-mRNA splicing by modifying the intracellular distribution of SRPK2.百草枯通过改变 SRPK2 的细胞内分布来调节选择性前体 mRNA 剪接。
PLoS One. 2013 Apr 16;8(4):e61980. doi: 10.1371/journal.pone.0061980. Print 2013.
6
PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.PRCC是乳头状肾细胞癌中最常见的TFE3融合伴侣,与前体mRNA剪接因子有关。
Oncogene. 2001 Jan 11;20(2):178-87. doi: 10.1038/sj.onc.1204056.
7
Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.抑制 SRSF9 通过降低谷胱甘肽过氧化物酶 4 的表达增强结直肠癌细胞对 erastin 诱导的铁死亡敏感性。
Int J Biochem Cell Biol. 2021 May;134:105948. doi: 10.1016/j.biocel.2021.105948. Epub 2021 Feb 17.
8
Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.铁蛋白自噬是溴结构域蛋白 BRD4 抑制剂 (+)-JQ1 在癌细胞中诱导铁死亡所必需的。
Cell Death Dis. 2019 Apr 15;10(5):331. doi: 10.1038/s41419-019-1564-7.
9
BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.BRD4抑制剂通过靶向活性氧(ROS)和FSP1,广泛促进不同细胞系中erastin诱导的铁死亡。
Discov Oncol. 2024 Apr 3;15(1):98. doi: 10.1007/s12672-024-00928-y.
10
Fission yeast mitotic regulator Dsk1 is an SR protein-specific kinase.裂殖酵母有丝分裂调节因子Dsk1是一种SR蛋白特异性激酶。
J Biol Chem. 1998 Mar 6;273(10):5963-9. doi: 10.1074/jbc.273.10.5963.

引用本文的文献

1
Transcriptomic analysis reveals lung cancer and subtype-specific alternative splicing biomarkers regulated by RNA-binding proteins.转录组分析揭示了由RNA结合蛋白调控的肺癌及亚型特异性可变剪接生物标志物。
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102681. doi: 10.1016/j.omtn.2025.102681. eCollection 2025 Sep 9.
2
Developing a machine-learning model to enable treatment selection for neoadjuvant chemotherapy for esophageal cancer.开发一种机器学习模型,以实现食管癌新辅助化疗的治疗选择。
Sci Rep. 2025 Jul 15;15(1):25669. doi: 10.1038/s41598-025-11252-y.
3
BRD4 silencing attenuates hemin-induced neuronal ferroptosis and inflammation via the H3K27ac-ATF3 axis in an in vitro model of cerebral hemorrhage.

本文引用的文献

1
Cohesin regulates alternative splicing.黏连蛋白调控可变剪接。
Sci Adv. 2023 Mar;9(9):eade3876. doi: 10.1126/sciadv.ade3876. Epub 2023 Mar 1.
2
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers.ACSL3和ACSL4在铁死亡和癌症中的不同作用。
Cancers (Basel). 2022 Nov 29;14(23):5896. doi: 10.3390/cancers14235896.
3
Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis.溴结构域蛋白 4(BRD4)作为脂肪酸代谢基因和铁死亡的表观遗传调节剂。
在脑出血的体外模型中,BRD4沉默通过H3K27ac-ATF3轴减轻血红素诱导的神经元铁死亡和炎症。
Eur J Med Res. 2025 Jul 2;30(1):556. doi: 10.1186/s40001-025-02759-1.
4
Comprehensive multi-omics analysis of histone acetylation modulators identifies ASH1L as a novel aggressive marker for osteosarcoma.组蛋白乙酰化调节剂的综合多组学分析确定ASH1L为骨肉瘤的一种新型侵袭性标志物。
Discov Oncol. 2025 Jun 12;16(1):1070. doi: 10.1007/s12672-025-02920-6.
5
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets.骨肉瘤中的脂质代谢重编程及相关铁死亡:从分子机制到潜在靶点
J Bone Oncol. 2025 Jan 26;51:100660. doi: 10.1016/j.jbo.2025.100660. eCollection 2025 Apr.
6
Epigenetic regulation of targeted ferroptosis: A new strategy for drug development.靶向铁死亡的表观遗传调控:药物开发的新策略。
J Pharm Anal. 2024 Oct;14(10):101012. doi: 10.1016/j.jpha.2024.101012. Epub 2024 May 28.
7
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC.转录因子MEF2D调节ACSL3的异常表达并通过抑制肝癌中的铁死亡增强索拉非尼耐药性。
Front Pharmacol. 2024 Dec 18;15:1464852. doi: 10.3389/fphar.2024.1464852. eCollection 2024.
8
SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression.小核核糖核蛋白70(SNRNP70)调节CD55的剪接以促进骨肉瘤进展。
JCI Insight. 2024 Dec 20;9(24):e185269. doi: 10.1172/jci.insight.185269.
Cell Death Dis. 2022 Oct 29;13(10):912. doi: 10.1038/s41419-022-05344-0.
4
Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances.肿瘤中的纳米增强光合作用以激活脂质过氧化作用克服癌症耐药性。
Biomaterials. 2022 Jun;285:121561. doi: 10.1016/j.biomaterials.2022.121561. Epub 2022 May 3.
5
CD8 T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4.CD8 T 细胞和脂肪酸通过 ACSL4 调控肿瘤铁死亡和免疫。
Cancer Cell. 2022 Apr 11;40(4):365-378.e6. doi: 10.1016/j.ccell.2022.02.003. Epub 2022 Feb 24.
6
Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells.Fin56 诱导的铁死亡受到自噬介导的 GPX4 降解的支持,并与 mTOR 抑制协同作用,杀死膀胱癌细胞。
Cell Death Dis. 2021 Oct 29;12(11):1028. doi: 10.1038/s41419-021-04306-2.
7
Phosphorylation regulates arginine-rich RNA-binding protein solubility and oligomerization.磷酸化调节富含精氨酸的RNA结合蛋白的溶解度和寡聚化。
J Biol Chem. 2021 Nov;297(5):101306. doi: 10.1016/j.jbc.2021.101306. Epub 2021 Oct 19.
8
Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells.抑制 GPX4 或 mTOR 通过促进 NSCLC 细胞铁死亡克服拉帕替尼耐药。
Biochem Biophys Res Commun. 2021 Aug 27;567:154-160. doi: 10.1016/j.bbrc.2021.06.051. Epub 2021 Jun 20.
9
Splicing factor SRSF2-centric gene regulation.剪接因子 SRSF2 为中心的基因调控。
Int J Biol Sci. 2021 Apr 16;17(7):1708-1715. doi: 10.7150/ijbs.58888. eCollection 2021.
10
Blue light-triggered Fe-release from monodispersed ferrihydrite nanoparticles for cancer iron therapy.蓝光触发单分散水铁矿纳米颗粒中铁的释放用于癌症铁疗。
Biomaterials. 2021 Apr;271:120739. doi: 10.1016/j.biomaterials.2021.120739. Epub 2021 Mar 3.